TY  - JOUR
AU  - Anastasovska, Violeta
AU  - Kocova, Mirjana
AU  - Zdraveska, Nikolina
AU  - Stojiljković, Maja
AU  - Skakić, Anita
AU  - Klaassen, Kristel
AU  - Pavlović, Sonja
PY  - 2021
UR  - https://imagine.imgge.bg.ac.rs/handle/123456789/1411
AB  - Background Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder of adrenal steroidogenesis with a broad spectrum of clinical presentations, ranging from the severe classical salt-wasting (SW) and simple-virilizing (SV) form, to the mild nonclassical form. A large variety of CYP21A2 genotypes in correlation with phenotype have been described. Materials and methods DNA samples from a 14-day-old male newborn with clinical and laboratory signs of SW CAH and family members were subjected for molecular analysis of the nine most common point CYP21A2 mutations by ACRS/PCR method. Direct DNA sequencing of the whole CYP21A2 gene was performed to detect the second mutant allele in the patient. The in silico predicting analysis and the crystal structure analysis of the mutated CYP21A2 protein have been performed. Results Molecular analysis confirmed that the patient was compound heterozygote carrying p.Q318X mutation inherited from the mother and a novel c.1271_1279delGTGCCCGCG (p.G424_R426del) variant in exon 10 inherited from the father. The in silico predicting software tools classified the novel mutation as pathogenic. Crystal structure analysis showed that the three residues affected by the novel in-frame deletion form several hydrogen bonds that could lead to impaired stability and function of the CYP21A2 protein. These findings were concordant with the patient's phenotype. The need of several molecular methods to elucidate the genotype in this patient has also been discussed. Conclusions A novel 9 bp deletion in CYP21A2 gene with predicted pathogenic effect on the enzyme activity was detected in neonatal patient causing severe SW CAH.
PB  - Springer, New York
T2  - Endocrine
T1  - A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia
EP  - 202
IS  - 1
SP  - 196
VL  - 73
DO  - 10.1007/s12020-021-02680-7
ER  - 

@article{
author = "Anastasovska, Violeta and Kocova, Mirjana and Zdraveska, Nikolina and Stojiljković, Maja and Skakić, Anita and Klaassen, Kristel and Pavlović, Sonja",
year = "2021",
abstract = "Background Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder of adrenal steroidogenesis with a broad spectrum of clinical presentations, ranging from the severe classical salt-wasting (SW) and simple-virilizing (SV) form, to the mild nonclassical form. A large variety of CYP21A2 genotypes in correlation with phenotype have been described. Materials and methods DNA samples from a 14-day-old male newborn with clinical and laboratory signs of SW CAH and family members were subjected for molecular analysis of the nine most common point CYP21A2 mutations by ACRS/PCR method. Direct DNA sequencing of the whole CYP21A2 gene was performed to detect the second mutant allele in the patient. The in silico predicting analysis and the crystal structure analysis of the mutated CYP21A2 protein have been performed. Results Molecular analysis confirmed that the patient was compound heterozygote carrying p.Q318X mutation inherited from the mother and a novel c.1271_1279delGTGCCCGCG (p.G424_R426del) variant in exon 10 inherited from the father. The in silico predicting software tools classified the novel mutation as pathogenic. Crystal structure analysis showed that the three residues affected by the novel in-frame deletion form several hydrogen bonds that could lead to impaired stability and function of the CYP21A2 protein. These findings were concordant with the patient's phenotype. The need of several molecular methods to elucidate the genotype in this patient has also been discussed. Conclusions A novel 9 bp deletion in CYP21A2 gene with predicted pathogenic effect on the enzyme activity was detected in neonatal patient causing severe SW CAH.",
publisher = "Springer, New York",
journal = "Endocrine",
title = "A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia",
pages = "202-196",
number = "1",
volume = "73",
doi = "10.1007/s12020-021-02680-7"
}

Anastasovska, V., Kocova, M., Zdraveska, N., Stojiljković, M., Skakić, A., Klaassen, K.,& Pavlović, S.. (2021). A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia. in Endocrine
Springer, New York., 73(1), 196-202.
https://doi.org/10.1007/s12020-021-02680-7

Anastasovska V, Kocova M, Zdraveska N, Stojiljković M, Skakić A, Klaassen K, Pavlović S. A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia. in Endocrine. 2021;73(1):196-202.
doi:10.1007/s12020-021-02680-7 .

Anastasovska, Violeta, Kocova, Mirjana, Zdraveska, Nikolina, Stojiljković, Maja, Skakić, Anita, Klaassen, Kristel, Pavlović, Sonja, "A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia" in Endocrine, 73, no. 1 (2021):196-202,
https://doi.org/10.1007/s12020-021-02680-7 . .